nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP3A4—bone cancer	0.839	1	CbGaD
Bisoprolol—Chlorphenesin—CYP3A4—bone cancer	0.000797	0.421	CrCbGaD
Bisoprolol—Chlorphenesin—PTGS2—bone cancer	0.00078	0.413	CrCbGaD
Bisoprolol—Cardiac arrest—Doxorubicin—bone cancer	0.000365	0.0023	CcSEcCtD
Bisoprolol—Mood swings—Doxorubicin—bone cancer	0.000364	0.00229	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000362	0.00228	CcSEcCtD
Bisoprolol—Asthma—Epirubicin—bone cancer	0.000359	0.00226	CcSEcCtD
Bisoprolol—Paraesthesia—Cisplatin—bone cancer	0.000357	0.00224	CcSEcCtD
Bisoprolol—Dyspnoea—Cisplatin—bone cancer	0.000354	0.00223	CcSEcCtD
Bisoprolol—Erectile dysfunction—Methotrexate—bone cancer	0.000353	0.00222	CcSEcCtD
Bisoprolol—Abdominal pain upper—Doxorubicin—bone cancer	0.000351	0.00221	CcSEcCtD
Bisoprolol—Orthostatic hypotension—Doxorubicin—bone cancer	0.000351	0.00221	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Methotrexate—bone cancer	0.00035	0.0022	CcSEcCtD
Bisoprolol—Breast disorder—Doxorubicin—bone cancer	0.000347	0.00218	CcSEcCtD
Bisoprolol—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000346	0.00218	CcSEcCtD
Bisoprolol—Bronchitis—Epirubicin—bone cancer	0.000345	0.00217	CcSEcCtD
Bisoprolol—Pneumonia—Methotrexate—bone cancer	0.000344	0.00216	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Cisplatin—bone cancer	0.000343	0.00216	CcSEcCtD
Bisoprolol—Drowsiness—Methotrexate—bone cancer	0.000342	0.00215	CcSEcCtD
Bisoprolol—Depression—Methotrexate—bone cancer	0.000341	0.00214	CcSEcCtD
Bisoprolol—Gastritis—Doxorubicin—bone cancer	0.00034	0.00214	CcSEcCtD
Bisoprolol—Pain—Cisplatin—bone cancer	0.00034	0.00214	CcSEcCtD
Bisoprolol—Muscular weakness—Doxorubicin—bone cancer	0.000339	0.00213	CcSEcCtD
Bisoprolol—Conjunctivitis—Methotrexate—bone cancer	0.000332	0.00209	CcSEcCtD
Bisoprolol—Asthma—Doxorubicin—bone cancer	0.000332	0.00209	CcSEcCtD
Bisoprolol—Sweating—Methotrexate—bone cancer	0.000328	0.00206	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Epirubicin—bone cancer	0.000328	0.00206	CcSEcCtD
Bisoprolol—Feeling abnormal—Cisplatin—bone cancer	0.000327	0.00206	CcSEcCtD
Bisoprolol—Weight increased—Epirubicin—bone cancer	0.000327	0.00205	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Methotrexate—bone cancer	0.000323	0.00203	CcSEcCtD
Bisoprolol—Pneumonia—Epirubicin—bone cancer	0.000322	0.00202	CcSEcCtD
Bisoprolol—Drowsiness—Epirubicin—bone cancer	0.00032	0.00201	CcSEcCtD
Bisoprolol—Bronchitis—Doxorubicin—bone cancer	0.000319	0.00201	CcSEcCtD
Bisoprolol—Agranulocytosis—Methotrexate—bone cancer	0.000319	0.00201	CcSEcCtD
Bisoprolol—Body temperature increased—Cisplatin—bone cancer	0.000314	0.00198	CcSEcCtD
Bisoprolol—Propranolol—CYP3A4—bone cancer	0.000313	0.166	CrCbGaD
Bisoprolol—Conjunctivitis—Epirubicin—bone cancer	0.000311	0.00196	CcSEcCtD
Bisoprolol—Urinary tract infection—Epirubicin—bone cancer	0.000311	0.00196	CcSEcCtD
Bisoprolol—Hepatitis—Methotrexate—bone cancer	0.000307	0.00193	CcSEcCtD
Bisoprolol—Sweating—Epirubicin—bone cancer	0.000307	0.00193	CcSEcCtD
Bisoprolol—Pharyngitis—Methotrexate—bone cancer	0.000305	0.00192	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Doxorubicin—bone cancer	0.000303	0.00191	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Epirubicin—bone cancer	0.000303	0.0019	CcSEcCtD
Bisoprolol—Weight increased—Doxorubicin—bone cancer	0.000302	0.0019	CcSEcCtD
Bisoprolol—Sinusitis—Epirubicin—bone cancer	0.0003	0.00189	CcSEcCtD
Bisoprolol—Agranulocytosis—Epirubicin—bone cancer	0.000299	0.00188	CcSEcCtD
Bisoprolol—Pneumonia—Doxorubicin—bone cancer	0.000298	0.00187	CcSEcCtD
Bisoprolol—Drowsiness—Doxorubicin—bone cancer	0.000296	0.00186	CcSEcCtD
Bisoprolol—Visual impairment—Methotrexate—bone cancer	0.000296	0.00186	CcSEcCtD
Bisoprolol—Hypersensitivity—Cisplatin—bone cancer	0.000293	0.00184	CcSEcCtD
Bisoprolol—Bradycardia—Epirubicin—bone cancer	0.000292	0.00184	CcSEcCtD
Bisoprolol—Rhinitis—Epirubicin—bone cancer	0.000288	0.00181	CcSEcCtD
Bisoprolol—Conjunctivitis—Doxorubicin—bone cancer	0.000288	0.00181	CcSEcCtD
Bisoprolol—Urinary tract infection—Doxorubicin—bone cancer	0.000288	0.00181	CcSEcCtD
Bisoprolol—Hepatitis—Epirubicin—bone cancer	0.000287	0.00181	CcSEcCtD
Bisoprolol—Eye disorder—Methotrexate—bone cancer	0.000287	0.0018	CcSEcCtD
Bisoprolol—Tinnitus—Methotrexate—bone cancer	0.000286	0.0018	CcSEcCtD
Bisoprolol—Hypoaesthesia—Epirubicin—bone cancer	0.000286	0.0018	CcSEcCtD
Bisoprolol—Asthenia—Cisplatin—bone cancer	0.000285	0.00179	CcSEcCtD
Bisoprolol—Pharyngitis—Epirubicin—bone cancer	0.000285	0.00179	CcSEcCtD
Bisoprolol—Cardiac disorder—Methotrexate—bone cancer	0.000285	0.00179	CcSEcCtD
Bisoprolol—Sweating—Doxorubicin—bone cancer	0.000284	0.00178	CcSEcCtD
Bisoprolol—Oedema peripheral—Epirubicin—bone cancer	0.000283	0.00178	CcSEcCtD
Bisoprolol—Connective tissue disorder—Epirubicin—bone cancer	0.000282	0.00177	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Doxorubicin—bone cancer	0.00028	0.00176	CcSEcCtD
Bisoprolol—Angiopathy—Methotrexate—bone cancer	0.000278	0.00175	CcSEcCtD
Bisoprolol—Sinusitis—Doxorubicin—bone cancer	0.000278	0.00175	CcSEcCtD
Bisoprolol—Visual impairment—Epirubicin—bone cancer	0.000277	0.00174	CcSEcCtD
Bisoprolol—Mediastinal disorder—Methotrexate—bone cancer	0.000277	0.00174	CcSEcCtD
Bisoprolol—Agranulocytosis—Doxorubicin—bone cancer	0.000276	0.00174	CcSEcCtD
Bisoprolol—Diarrhoea—Cisplatin—bone cancer	0.000272	0.00171	CcSEcCtD
Bisoprolol—Alopecia—Methotrexate—bone cancer	0.000271	0.00171	CcSEcCtD
Bisoprolol—Bradycardia—Doxorubicin—bone cancer	0.000271	0.0017	CcSEcCtD
Bisoprolol—Mental disorder—Methotrexate—bone cancer	0.000269	0.00169	CcSEcCtD
Bisoprolol—Eye disorder—Epirubicin—bone cancer	0.000268	0.00169	CcSEcCtD
Bisoprolol—Tinnitus—Epirubicin—bone cancer	0.000268	0.00168	CcSEcCtD
Bisoprolol—Erythema—Methotrexate—bone cancer	0.000267	0.00168	CcSEcCtD
Bisoprolol—Flushing—Epirubicin—bone cancer	0.000267	0.00168	CcSEcCtD
Bisoprolol—Cardiac disorder—Epirubicin—bone cancer	0.000267	0.00168	CcSEcCtD
Bisoprolol—Rhinitis—Doxorubicin—bone cancer	0.000266	0.00168	CcSEcCtD
Bisoprolol—Hepatitis—Doxorubicin—bone cancer	0.000266	0.00167	CcSEcCtD
Bisoprolol—Hypoaesthesia—Doxorubicin—bone cancer	0.000264	0.00166	CcSEcCtD
Bisoprolol—Pharyngitis—Doxorubicin—bone cancer	0.000264	0.00166	CcSEcCtD
Bisoprolol—Oedema peripheral—Doxorubicin—bone cancer	0.000262	0.00165	CcSEcCtD
Bisoprolol—Dysgeusia—Methotrexate—bone cancer	0.000262	0.00165	CcSEcCtD
Bisoprolol—Connective tissue disorder—Doxorubicin—bone cancer	0.000261	0.00164	CcSEcCtD
Bisoprolol—Angiopathy—Epirubicin—bone cancer	0.000261	0.00164	CcSEcCtD
Bisoprolol—Mediastinal disorder—Epirubicin—bone cancer	0.000259	0.00163	CcSEcCtD
Bisoprolol—Back pain—Methotrexate—bone cancer	0.000258	0.00162	CcSEcCtD
Bisoprolol—Arrhythmia—Epirubicin—bone cancer	0.000257	0.00161	CcSEcCtD
Bisoprolol—Visual impairment—Doxorubicin—bone cancer	0.000256	0.00161	CcSEcCtD
Bisoprolol—Alopecia—Epirubicin—bone cancer	0.000254	0.0016	CcSEcCtD
Bisoprolol—Vomiting—Cisplatin—bone cancer	0.000253	0.00159	CcSEcCtD
Bisoprolol—Mental disorder—Epirubicin—bone cancer	0.000252	0.00158	CcSEcCtD
Bisoprolol—Rash—Cisplatin—bone cancer	0.000251	0.00158	CcSEcCtD
Bisoprolol—Dermatitis—Cisplatin—bone cancer	0.00025	0.00157	CcSEcCtD
Bisoprolol—Erythema—Epirubicin—bone cancer	0.00025	0.00157	CcSEcCtD
Bisoprolol—Eye disorder—Doxorubicin—bone cancer	0.000248	0.00156	CcSEcCtD
Bisoprolol—Ill-defined disorder—Methotrexate—bone cancer	0.000248	0.00156	CcSEcCtD
Bisoprolol—Tinnitus—Doxorubicin—bone cancer	0.000248	0.00156	CcSEcCtD
Bisoprolol—Cardiac disorder—Doxorubicin—bone cancer	0.000247	0.00155	CcSEcCtD
Bisoprolol—Flushing—Doxorubicin—bone cancer	0.000247	0.00155	CcSEcCtD
Bisoprolol—Dysgeusia—Epirubicin—bone cancer	0.000245	0.00154	CcSEcCtD
Bisoprolol—Back pain—Epirubicin—bone cancer	0.000242	0.00152	CcSEcCtD
Bisoprolol—Angiopathy—Doxorubicin—bone cancer	0.000241	0.00152	CcSEcCtD
Bisoprolol—Malaise—Methotrexate—bone cancer	0.000241	0.00151	CcSEcCtD
Bisoprolol—Muscle spasms—Epirubicin—bone cancer	0.00024	0.00151	CcSEcCtD
Bisoprolol—Vertigo—Methotrexate—bone cancer	0.00024	0.00151	CcSEcCtD
Bisoprolol—Mediastinal disorder—Doxorubicin—bone cancer	0.00024	0.00151	CcSEcCtD
Bisoprolol—Arrhythmia—Doxorubicin—bone cancer	0.000237	0.00149	CcSEcCtD
Bisoprolol—Nausea—Cisplatin—bone cancer	0.000236	0.00148	CcSEcCtD
Bisoprolol—Alopecia—Doxorubicin—bone cancer	0.000235	0.00148	CcSEcCtD
Bisoprolol—Cough—Methotrexate—bone cancer	0.000233	0.00147	CcSEcCtD
Bisoprolol—Mental disorder—Doxorubicin—bone cancer	0.000233	0.00146	CcSEcCtD
Bisoprolol—Ill-defined disorder—Epirubicin—bone cancer	0.000232	0.00146	CcSEcCtD
Bisoprolol—Erythema—Doxorubicin—bone cancer	0.000231	0.00145	CcSEcCtD
Bisoprolol—Agitation—Epirubicin—bone cancer	0.00023	0.00144	CcSEcCtD
Bisoprolol—Myalgia—Methotrexate—bone cancer	0.000227	0.00143	CcSEcCtD
Bisoprolol—Arthralgia—Methotrexate—bone cancer	0.000227	0.00143	CcSEcCtD
Bisoprolol—Chest pain—Methotrexate—bone cancer	0.000227	0.00143	CcSEcCtD
Bisoprolol—Dysgeusia—Doxorubicin—bone cancer	0.000227	0.00142	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000226	0.00142	CcSEcCtD
Bisoprolol—Malaise—Epirubicin—bone cancer	0.000225	0.00142	CcSEcCtD
Bisoprolol—Discomfort—Methotrexate—bone cancer	0.000225	0.00141	CcSEcCtD
Bisoprolol—Vertigo—Epirubicin—bone cancer	0.000225	0.00141	CcSEcCtD
Bisoprolol—Syncope—Epirubicin—bone cancer	0.000224	0.00141	CcSEcCtD
Bisoprolol—Back pain—Doxorubicin—bone cancer	0.000224	0.00141	CcSEcCtD
Bisoprolol—Muscle spasms—Doxorubicin—bone cancer	0.000222	0.0014	CcSEcCtD
Bisoprolol—Palpitations—Epirubicin—bone cancer	0.000221	0.00139	CcSEcCtD
Bisoprolol—Confusional state—Methotrexate—bone cancer	0.00022	0.00138	CcSEcCtD
Bisoprolol—Loss of consciousness—Epirubicin—bone cancer	0.00022	0.00138	CcSEcCtD
Bisoprolol—Cough—Epirubicin—bone cancer	0.000218	0.00137	CcSEcCtD
Bisoprolol—Infection—Methotrexate—bone cancer	0.000217	0.00136	CcSEcCtD
Bisoprolol—Ill-defined disorder—Doxorubicin—bone cancer	0.000215	0.00135	CcSEcCtD
Bisoprolol—Nervous system disorder—Methotrexate—bone cancer	0.000214	0.00134	CcSEcCtD
Bisoprolol—Thrombocytopenia—Methotrexate—bone cancer	0.000213	0.00134	CcSEcCtD
Bisoprolol—Chest pain—Epirubicin—bone cancer	0.000213	0.00134	CcSEcCtD
Bisoprolol—Arthralgia—Epirubicin—bone cancer	0.000213	0.00134	CcSEcCtD
Bisoprolol—Myalgia—Epirubicin—bone cancer	0.000213	0.00134	CcSEcCtD
Bisoprolol—Agitation—Doxorubicin—bone cancer	0.000213	0.00134	CcSEcCtD
Bisoprolol—Anxiety—Epirubicin—bone cancer	0.000212	0.00133	CcSEcCtD
Bisoprolol—Skin disorder—Methotrexate—bone cancer	0.000212	0.00133	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000211	0.00133	CcSEcCtD
Bisoprolol—Hyperhidrosis—Methotrexate—bone cancer	0.000211	0.00133	CcSEcCtD
Bisoprolol—Discomfort—Epirubicin—bone cancer	0.00021	0.00132	CcSEcCtD
Bisoprolol—Malaise—Doxorubicin—bone cancer	0.000209	0.00131	CcSEcCtD
Bisoprolol—Dry mouth—Epirubicin—bone cancer	0.000208	0.00131	CcSEcCtD
Bisoprolol—Vertigo—Doxorubicin—bone cancer	0.000208	0.00131	CcSEcCtD
Bisoprolol—Syncope—Doxorubicin—bone cancer	0.000207	0.0013	CcSEcCtD
Bisoprolol—Confusional state—Epirubicin—bone cancer	0.000206	0.00129	CcSEcCtD
Bisoprolol—Palpitations—Doxorubicin—bone cancer	0.000204	0.00129	CcSEcCtD
Bisoprolol—Oedema—Epirubicin—bone cancer	0.000204	0.00128	CcSEcCtD
Bisoprolol—Hypotension—Methotrexate—bone cancer	0.000204	0.00128	CcSEcCtD
Bisoprolol—Loss of consciousness—Doxorubicin—bone cancer	0.000203	0.00128	CcSEcCtD
Bisoprolol—Infection—Epirubicin—bone cancer	0.000203	0.00127	CcSEcCtD
Bisoprolol—Cough—Doxorubicin—bone cancer	0.000202	0.00127	CcSEcCtD
Bisoprolol—Shock—Epirubicin—bone cancer	0.000201	0.00126	CcSEcCtD
Bisoprolol—Nervous system disorder—Epirubicin—bone cancer	0.0002	0.00126	CcSEcCtD
Bisoprolol—Thrombocytopenia—Epirubicin—bone cancer	0.0002	0.00126	CcSEcCtD
Bisoprolol—Tachycardia—Epirubicin—bone cancer	0.000199	0.00125	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000199	0.00125	CcSEcCtD
Bisoprolol—Skin disorder—Epirubicin—bone cancer	0.000198	0.00125	CcSEcCtD
Bisoprolol—Hyperhidrosis—Epirubicin—bone cancer	0.000197	0.00124	CcSEcCtD
Bisoprolol—Insomnia—Methotrexate—bone cancer	0.000197	0.00124	CcSEcCtD
Bisoprolol—Myalgia—Doxorubicin—bone cancer	0.000197	0.00124	CcSEcCtD
Bisoprolol—Chest pain—Doxorubicin—bone cancer	0.000197	0.00124	CcSEcCtD
Bisoprolol—Arthralgia—Doxorubicin—bone cancer	0.000197	0.00124	CcSEcCtD
Bisoprolol—Anxiety—Doxorubicin—bone cancer	0.000196	0.00123	CcSEcCtD
Bisoprolol—Paraesthesia—Methotrexate—bone cancer	0.000196	0.00123	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000196	0.00123	CcSEcCtD
Bisoprolol—Discomfort—Doxorubicin—bone cancer	0.000195	0.00122	CcSEcCtD
Bisoprolol—Dyspnoea—Methotrexate—bone cancer	0.000194	0.00122	CcSEcCtD
Bisoprolol—Somnolence—Methotrexate—bone cancer	0.000194	0.00122	CcSEcCtD
Bisoprolol—Dry mouth—Doxorubicin—bone cancer	0.000193	0.00121	CcSEcCtD
Bisoprolol—Dyspepsia—Methotrexate—bone cancer	0.000192	0.00121	CcSEcCtD
Bisoprolol—Hypotension—Epirubicin—bone cancer	0.000191	0.0012	CcSEcCtD
Bisoprolol—Confusional state—Doxorubicin—bone cancer	0.00019	0.0012	CcSEcCtD
Bisoprolol—Oedema—Doxorubicin—bone cancer	0.000189	0.00119	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Methotrexate—bone cancer	0.000188	0.00118	CcSEcCtD
Bisoprolol—Fatigue—Methotrexate—bone cancer	0.000188	0.00118	CcSEcCtD
Bisoprolol—Infection—Doxorubicin—bone cancer	0.000188	0.00118	CcSEcCtD
Bisoprolol—Pain—Methotrexate—bone cancer	0.000186	0.00117	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000186	0.00117	CcSEcCtD
Bisoprolol—Shock—Doxorubicin—bone cancer	0.000186	0.00117	CcSEcCtD
Bisoprolol—Nervous system disorder—Doxorubicin—bone cancer	0.000185	0.00116	CcSEcCtD
Bisoprolol—Thrombocytopenia—Doxorubicin—bone cancer	0.000185	0.00116	CcSEcCtD
Bisoprolol—Insomnia—Epirubicin—bone cancer	0.000185	0.00116	CcSEcCtD
Bisoprolol—Tachycardia—Doxorubicin—bone cancer	0.000184	0.00116	CcSEcCtD
Bisoprolol—Skin disorder—Doxorubicin—bone cancer	0.000183	0.00115	CcSEcCtD
Bisoprolol—Paraesthesia—Epirubicin—bone cancer	0.000183	0.00115	CcSEcCtD
Bisoprolol—Hyperhidrosis—Doxorubicin—bone cancer	0.000183	0.00115	CcSEcCtD
Bisoprolol—Dyspnoea—Epirubicin—bone cancer	0.000182	0.00114	CcSEcCtD
Bisoprolol—Somnolence—Epirubicin—bone cancer	0.000181	0.00114	CcSEcCtD
Bisoprolol—Feeling abnormal—Methotrexate—bone cancer	0.00018	0.00113	CcSEcCtD
Bisoprolol—Dyspepsia—Epirubicin—bone cancer	0.00018	0.00113	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Methotrexate—bone cancer	0.000178	0.00112	CcSEcCtD
Bisoprolol—Hypotension—Doxorubicin—bone cancer	0.000176	0.00111	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Epirubicin—bone cancer	0.000176	0.00111	CcSEcCtD
Bisoprolol—Fatigue—Epirubicin—bone cancer	0.000176	0.00111	CcSEcCtD
Bisoprolol—Pain—Epirubicin—bone cancer	0.000174	0.0011	CcSEcCtD
Bisoprolol—Constipation—Epirubicin—bone cancer	0.000174	0.0011	CcSEcCtD
Bisoprolol—Urticaria—Methotrexate—bone cancer	0.000173	0.00109	CcSEcCtD
Bisoprolol—Body temperature increased—Methotrexate—bone cancer	0.000172	0.00108	CcSEcCtD
Bisoprolol—Abdominal pain—Methotrexate—bone cancer	0.000172	0.00108	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000172	0.00108	CcSEcCtD
Bisoprolol—Insomnia—Doxorubicin—bone cancer	0.000171	0.00107	CcSEcCtD
Bisoprolol—Paraesthesia—Doxorubicin—bone cancer	0.00017	0.00107	CcSEcCtD
Bisoprolol—Dyspnoea—Doxorubicin—bone cancer	0.000168	0.00106	CcSEcCtD
Bisoprolol—Feeling abnormal—Epirubicin—bone cancer	0.000168	0.00106	CcSEcCtD
Bisoprolol—Somnolence—Doxorubicin—bone cancer	0.000168	0.00106	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Epirubicin—bone cancer	0.000167	0.00105	CcSEcCtD
Bisoprolol—Dyspepsia—Doxorubicin—bone cancer	0.000166	0.00105	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000163	0.00102	CcSEcCtD
Bisoprolol—Fatigue—Doxorubicin—bone cancer	0.000163	0.00102	CcSEcCtD
Bisoprolol—Urticaria—Epirubicin—bone cancer	0.000162	0.00102	CcSEcCtD
Bisoprolol—Pain—Doxorubicin—bone cancer	0.000161	0.00102	CcSEcCtD
Bisoprolol—Constipation—Doxorubicin—bone cancer	0.000161	0.00102	CcSEcCtD
Bisoprolol—Body temperature increased—Epirubicin—bone cancer	0.000161	0.00101	CcSEcCtD
Bisoprolol—Abdominal pain—Epirubicin—bone cancer	0.000161	0.00101	CcSEcCtD
Bisoprolol—Hypersensitivity—Methotrexate—bone cancer	0.000161	0.00101	CcSEcCtD
Bisoprolol—Asthenia—Methotrexate—bone cancer	0.000156	0.000984	CcSEcCtD
Bisoprolol—Feeling abnormal—Doxorubicin—bone cancer	0.000156	0.000978	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Doxorubicin—bone cancer	0.000154	0.000971	CcSEcCtD
Bisoprolol—Pruritus—Methotrexate—bone cancer	0.000154	0.00097	CcSEcCtD
Bisoprolol—Hypersensitivity—Epirubicin—bone cancer	0.00015	0.000945	CcSEcCtD
Bisoprolol—Urticaria—Doxorubicin—bone cancer	0.00015	0.000943	CcSEcCtD
Bisoprolol—Abdominal pain—Doxorubicin—bone cancer	0.000149	0.000938	CcSEcCtD
Bisoprolol—Body temperature increased—Doxorubicin—bone cancer	0.000149	0.000938	CcSEcCtD
Bisoprolol—Diarrhoea—Methotrexate—bone cancer	0.000149	0.000938	CcSEcCtD
Bisoprolol—Asthenia—Epirubicin—bone cancer	0.000146	0.000921	CcSEcCtD
Bisoprolol—Pruritus—Epirubicin—bone cancer	0.000144	0.000908	CcSEcCtD
Bisoprolol—Dizziness—Methotrexate—bone cancer	0.000144	0.000907	CcSEcCtD
Bisoprolol—Diarrhoea—Epirubicin—bone cancer	0.00014	0.000878	CcSEcCtD
Bisoprolol—Hypersensitivity—Doxorubicin—bone cancer	0.000139	0.000875	CcSEcCtD
Bisoprolol—Vomiting—Methotrexate—bone cancer	0.000139	0.000872	CcSEcCtD
Bisoprolol—Rash—Methotrexate—bone cancer	0.000137	0.000864	CcSEcCtD
Bisoprolol—Dermatitis—Methotrexate—bone cancer	0.000137	0.000864	CcSEcCtD
Bisoprolol—Headache—Methotrexate—bone cancer	0.000137	0.000859	CcSEcCtD
Bisoprolol—Asthenia—Doxorubicin—bone cancer	0.000135	0.000852	CcSEcCtD
Bisoprolol—Dizziness—Epirubicin—bone cancer	0.000135	0.000848	CcSEcCtD
Bisoprolol—Pruritus—Doxorubicin—bone cancer	0.000134	0.00084	CcSEcCtD
Bisoprolol—Vomiting—Epirubicin—bone cancer	0.00013	0.000816	CcSEcCtD
Bisoprolol—Nausea—Methotrexate—bone cancer	0.00013	0.000814	CcSEcCtD
Bisoprolol—Diarrhoea—Doxorubicin—bone cancer	0.000129	0.000812	CcSEcCtD
Bisoprolol—Rash—Epirubicin—bone cancer	0.000129	0.000809	CcSEcCtD
Bisoprolol—Dermatitis—Epirubicin—bone cancer	0.000129	0.000808	CcSEcCtD
Bisoprolol—Headache—Epirubicin—bone cancer	0.000128	0.000804	CcSEcCtD
Bisoprolol—Dizziness—Doxorubicin—bone cancer	0.000125	0.000785	CcSEcCtD
Bisoprolol—Nausea—Epirubicin—bone cancer	0.000121	0.000762	CcSEcCtD
Bisoprolol—Vomiting—Doxorubicin—bone cancer	0.00012	0.000755	CcSEcCtD
Bisoprolol—Rash—Doxorubicin—bone cancer	0.000119	0.000749	CcSEcCtD
Bisoprolol—Dermatitis—Doxorubicin—bone cancer	0.000119	0.000748	CcSEcCtD
Bisoprolol—Headache—Doxorubicin—bone cancer	0.000118	0.000744	CcSEcCtD
Bisoprolol—Nausea—Doxorubicin—bone cancer	0.000112	0.000705	CcSEcCtD
